Alexei Gogolev
Stock Analyst at JP Morgan
(3.71)
# 589
Out of 5,182 analysts
102
Total ratings
55.41%
Success rate
6.85%
Average return
Main Sectors:
Stocks Rated by Alexei Gogolev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRSN VeriSign | Maintains: Neutral | $273 → $278 | $269.20 | +3.27% | 3 | Apr 24, 2026 | |
| PHR Phreesia | Downgrades: Neutral | $24 → $16 | $9.54 | +67.71% | 3 | Mar 31, 2026 | |
| WIX Wix.com | Downgrades: Underweight | $114 → $91 | $75.67 | +20.26% | 6 | Mar 27, 2026 | |
| BRZE Braze | Maintains: Overweight | $32 → $33 | $23.27 | +41.81% | 2 | Mar 25, 2026 | |
| HQY HealthEquity | Maintains: Overweight | $129 → $123 | $82.45 | +49.18% | 2 | Mar 18, 2026 | |
| VEEV Veeva Systems | Maintains: Overweight | $330 → $296 | $161.13 | +83.70% | 2 | Feb 20, 2026 | |
| DOCS Doximity | Maintains: Neutral | $40 → $33 | $24.01 | +37.44% | 3 | Feb 20, 2026 | |
| INTA Intapp | Maintains: Overweight | $70 → $58 | $22.25 | +160.67% | 4 | Feb 4, 2026 | |
| PTC PTC Inc. | Downgrades: Underweight | $205 → $162 | $137.17 | +18.10% | 2 | Feb 2, 2026 | |
| APPF AppFolio | Maintains: Overweight | $330 → $300 | $169.29 | +77.21% | 5 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $46 → $48 | $29.96 | +60.21% | 5 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $74 | $37.33 | +98.23% | 1 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $26 | $24.15 | +7.66% | 6 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $56 → $51 | $33.44 | +52.51% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $200 | $86.04 | +132.45% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $86 → $94 | $67.29 | +39.69% | 3 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $101 | $36.44 | +177.17% | 6 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $271 → $288 | $139.56 | +106.36% | 9 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $85 | $55.40 | +53.43% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $45 | $16.23 | +177.26% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $10 → $11 | $11.71 | -6.06% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $526 | $342.03 | +53.79% | 3 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $36 → $32 | $5.65 | +466.37% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $28 | $7.90 | +254.43% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $247 → $249 | $118.98 | +109.28% | 4 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $73 → $55 | $53.00 | +3.77% | 4 | Mar 11, 2020 |
VeriSign
Apr 24, 2026
Maintains: Neutral
Price Target: $273 → $278
Current: $269.20
Upside: +3.27%
Phreesia
Mar 31, 2026
Downgrades: Neutral
Price Target: $24 → $16
Current: $9.54
Upside: +67.71%
Wix.com
Mar 27, 2026
Downgrades: Underweight
Price Target: $114 → $91
Current: $75.67
Upside: +20.26%
Braze
Mar 25, 2026
Maintains: Overweight
Price Target: $32 → $33
Current: $23.27
Upside: +41.81%
HealthEquity
Mar 18, 2026
Maintains: Overweight
Price Target: $129 → $123
Current: $82.45
Upside: +49.18%
Veeva Systems
Feb 20, 2026
Maintains: Overweight
Price Target: $330 → $296
Current: $161.13
Upside: +83.70%
Doximity
Feb 20, 2026
Maintains: Neutral
Price Target: $40 → $33
Current: $24.01
Upside: +37.44%
Intapp
Feb 4, 2026
Maintains: Overweight
Price Target: $70 → $58
Current: $22.25
Upside: +160.67%
PTC Inc.
Feb 2, 2026
Downgrades: Underweight
Price Target: $205 → $162
Current: $137.17
Upside: +18.10%
AppFolio
Jan 30, 2026
Maintains: Overweight
Price Target: $330 → $300
Current: $169.29
Upside: +77.21%
Dec 5, 2025
Maintains: Neutral
Price Target: $46 → $48
Current: $29.96
Upside: +60.21%
Dec 5, 2025
Maintains: Overweight
Price Target: $65 → $74
Current: $37.33
Upside: +98.23%
Nov 6, 2025
Maintains: Overweight
Price Target: $28 → $26
Current: $24.15
Upside: +7.66%
Nov 6, 2025
Maintains: Neutral
Price Target: $56 → $51
Current: $33.44
Upside: +52.51%
Oct 31, 2025
Maintains: Overweight
Price Target: $222 → $200
Current: $86.04
Upside: +132.45%
Jul 24, 2025
Maintains: Neutral
Price Target: $86 → $94
Current: $67.29
Upside: +39.69%
Jul 23, 2025
Maintains: Overweight
Price Target: $87 → $101
Current: $36.44
Upside: +177.17%
Jun 25, 2025
Maintains: Overweight
Price Target: $271 → $288
Current: $139.56
Upside: +106.36%
Apr 9, 2025
Maintains: Overweight
Price Target: $97 → $85
Current: $55.40
Upside: +53.43%
Dec 9, 2024
Maintains: Overweight
Price Target: $42 → $45
Current: $16.23
Upside: +177.26%
Aug 7, 2024
Maintains: Underweight
Price Target: $10 → $11
Current: $11.71
Upside: -6.06%
Feb 15, 2024
Maintains: Overweight
Price Target: $500 → $526
Current: $342.03
Upside: +53.79%
Aug 9, 2023
Maintains: Underweight
Price Target: $36 → $32
Current: $5.65
Upside: +466.37%
Jul 31, 2023
Maintains: Outperform
Price Target: $27 → $28
Current: $7.90
Upside: +254.43%
Mar 11, 2020
Maintains: Overweight
Price Target: $247 → $249
Current: $118.98
Upside: +109.28%
Mar 11, 2020
Upgrades: Neutral
Price Target: $73 → $55
Current: $53.00
Upside: +3.77%